Apira Science Successfully Completes Clinical Trial For The Treatment Of Androgenetic Alopecia In Females
3/18/2014 9:49:38 AM
IRVINE, Calif.--(BUSINESS WIRE)--Apira Science, Inc. today announced that it has successfully completed a clinical trial using its iGrow® Hair Growth System to promote hair growth in females. The study found promising results for the use of low-level laser therapy (LLLT) in increasing terminal hair counts in women. The iGrow Hair Growth System is a highly effective, in-home, hands-free LLLT hair growth device that has already been cleared by the FDA to promote hair growth in males.
Help employers find you! Check out all the jobs and post your resume.
comments powered by